Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Medsol RX

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Medsol RX head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 119 · Grade C

Medsol RX

Visit Medsol RX Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 73 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make Medsol RX a bad call — it's best for readers interested in included coaching who can confirm the exact package, dose coverage and renewal price before enrolling. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
48
Supply Reliability
95
72
Transparency
90
88
Access Breadth
93
90
Clinical Oversight
92
80
Track Record
88
68
CoreAge RxBrief Score 94 · 73Medsol RX

Price, coverage & the tracker

CoreAge RxMedsol RX
Brief Score94/100 (A)73/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

$199/mo ongoing

First month $169; three-month package $507 upfront. Confirm the selected quote and dose coverage; other pages show different figures.

Full price details

$199/month ongoing compounded semaglutide package; $169 first month; $507 upfront for the listed 3-month plan; confirm dose-specific quote

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

$259/mo ongoing

First month $239; three-month package $687 upfront. Confirm the selected quote and dose coverage; other pages show different figures.

Full price details

$259/month ongoing compounded tirzepatide package; $239 first month; $687 upfront for the listed 3-month plan; confirm dose-specific quote

CoverageUS only; restrictions by state, confirmed at intakeAdvertises nationwide service; confirm state-specific provider and pharmacy availability
Brand-name accessNot confirmedNot confirmed
Oral / sublingualInjection onlyInjection only
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

Medsol RX: Package-page monthly pricing is $169 then $199 for semaglutide and $239 then $259 for tirzepatide. Confirm the quote because other pages show different figures.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.